Argyremia in septal cauterization with silver nitrate

Journal of Otolaryngology

Volumn 28, Issue 4, 1999, Pages 211-216

  Nguyen, Rémy C L ^a   Leclerc, Jacques E ^a   Nantel, Albert ^a   Dumas, Pierre ^a   LeBlanc, Alain ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Argyremia; Argyria; Epistaxis; Inductively coupled plasma mass spectrometry; Silver; Silver nitrate

Indexed keywords

SILVER NITRATE;

ADOLESCENT; ADULT; AGED; ARGYREMIA; ARGYRIA; ARTICLE; BLOOD ANALYSIS; CAUTERIZATION; CLINICAL ARTICLE; EPISTAXIS; FEMALE; HAIR ANALYSIS; HUMAN; MALE; NOSE SEPTUM; PRIORITY JOURNAL; SCHOOL CHILD; SURGICAL TECHNIQUE;

ABSORPTION; ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS, LOCAL; CAUTERY; CHILD; EPISTAXIS; FEMALE; HAIR; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; NASAL SEPTUM; PROSPECTIVE STUDIES; SILVER; SILVER NITRATE; SPECTROPHOTOMETRY, ATOMIC;

EID: 0032876589     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Petering HG. Pharmacology and toxicology of heavy metals: silver. Pharmacol Ther 1976; 1:127-130.
2. Rosenman KD, Moss MD, Kon S. Argyria: clinical implications of exposure to silver nitrate and silver oxide. J Occup Med 1979; 21:430-435.
3. Greene RM, Su WPD. Argyria. Am Fam Physician 1987; 36: 151-154.
4. Lee SM, Lee SH. Generalized argyria after habitual use of AgNO3. J Dermatol 1994; 21:50-53.
5. Prescott RJ, Wells S. Systemic argyria. J Clin Pathol 1994; 47:556-557.
6. Espinel ML, Ferrando L. Asymptomatic blue nevus-like macule. Arch Dermatol 1996; 132:459-464.
7. Buckley WR. Localized argyria. Arch Dermatol 1963; 88: 531-539.
8. Prose PH. An electron microscopic study of human generalized argyria. Am J Pathol 1963; 42:293-299.
9. Matsumura T, Kumakiri M, Ohkawara A. Detection of selenium in generalized and localized argyria: report of four cases with x-ray microanalysis. J Dermatol 1992; 19:87-93.
10. Marshall JP, Schneider RP. Systemic argyria secondary to topical silver nitrate. Arch Dermatol 1977; 113:1077-1079.
11. U.S. Food and Drug Administration. Docket Management Branch. Rockville, MD: OTC Volume 100037-100039, 1973.
12. Fung MC, Bowen DL. Silver products for medical indications: risk-benefit assessment. J Toxicol Clin Toxicol 1996; 34:119-126.
13. Payne CM, Bladin C, Colchester AC. Argyria from excessive use of topical silver sulphadiazine [letter]. Lancet 1992; 340: 126.
14. Fung C, Weintraub M, Bowen DL. Colloidal silver proteins marketed as health supplements [letter]. JAMA 1995; 274: 1196-1197.
15. Fox CL, Modak SM, Stanford JW. Cerium sulphadiazine as a topical agent for burn wound infections: a comparison with silver sulphadiazine and zinc sulphadiazine. Burns 1977-78; 4:233-239.
16. Wan AT, Conyers RAJ, Coombs CJ. Determination of silver in blood, urine and tissues of volunteers and burn patients. Clin Chem 1991; 37:1683-1687.
17. Nuttall KL, Gordon WH, Ash KO. Inductively coupled plasma mass spectrometry for trace element analysis in the clinical laboratory. Ann Clin Lab Sci 1995; 25:264-271.
18. Houk RS. Mass spectrometry of inductively coupled plasmas. Anal Chem 1986; 58:97-105.
19. Hamilton EI, Minski MJ. Abundance of the chemical elements in man's diet and possible relations with environmental factors. Sci Total Environ 1972/1973; 1:375-394.
20. Perrelli G, Piolatto G. Tentative reference values for gold, silver and platinum: literature data analysis. Sci Total Environ 1992; 120:93-96.
21. Ryan RP, Terry CE. Silver. In: Toxicology desk reference: the toxic exposure and medical monitoring index. 3rd Ed. Washington, DC: Taylor & Francis, 1996:1856-1862.
22. Newton D, Holmes A. A case of accidental inhalation of zinc-65 and silver-110m. Radiat Res 1966; 29:403-412.
23. Smith LC, Carson BE. Silver: an appraisal of environmental exposure. Research Triangle Park, NC: National Institute of Environmental Health Science, 1977.
24. Armitage SA, White MA, Wilson HK. The determination of silver in whole blood and its application to biological monitoring of occupationally exposed groups. Ann Occup Hyg 1996; 40:331-338.
25. Furchner JF, Richmond CR, Drake GA. Retention of silver-110m in the mouse, rat, monkey and dog. Health Phys 1987; 15:505-514.
26. Bader KF. Organ deposition of silver following silver nitrate therapy of burns. Plast Reconstr Surg 1966; 37:550-551.
27. Tsipouras N, Rix CJ, Brady PH. Solubility of silver sulfadiazine in physiological media and relevance to treatment of thermal burns with silver sulfadiazine cream. Clin Chem 1995; 41:87-91.
28. Sugawara N, Sugawara C. Effect of silver on ceruloplasmin synthesis in relation to low-molecular-weight protein. Toxicol Lett 1984; 32:80-82.
29. Rungby J, Hultman P, Eriksen SE. Silver affects viability and structure of cultured mouse peritoneal macrophages and peroxidative capacity of whole mouse liver. Arch Toxicol 1987; 59:408-412.
30. Rosenman KD, Seixas N, Jacobs I. Potential nephrotoxic effects of exposure to silver. Br J Ind Med 1987; 44:267-272.
31. U.S. Environmental Protection Agency. Reference dose for chronic oral exposure of silver. CASRN 7440-22-4. Washington, DC: Chemical Screening and Risk Assessment Division, 1991.